IFACX
Price
$24.63
Change
-$0.11 (-0.44%)
Updated
Jan 22 closing price
Net Assets
128B
PAEAX
Price
$20.04
Change
+$0.07 (+0.35%)
Updated
Jan 22 closing price
Net Assets
2.73B
Ad is loading...

IFACX vs PAEAX

Header iconIFACX vs PAEAX Comparison
Open Charts IFACX vs PAEAXBanner chart's image
American Funds Income Fund of Amer C
Price$24.63
Change-$0.11 (-0.44%)
VolumeN/A
Net Assets128B
Putnam Dynamic Asset Allocation Gr A
Price$20.04
Change+$0.07 (+0.35%)
VolumeN/A
Net Assets2.73B
IFACX vs PAEAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IFACX vs. PAEAX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFACX is a Buy and PAEAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
IFACX has more cash in the bank: 128B vs. PAEAX (2.73B). IFACX pays higher dividends than PAEAX: IFACX (2.88) vs PAEAX (2.10). IFACX was incepted earlier than PAEAX: IFACX (24 years) vs PAEAX (31 years). PAEAX is a more actively managed with annual turnover of: 191.00 vs. IFACX (40.00). PAEAX has a lower initial minimum investment than IFACX: PAEAX (0) vs IFACX (250). IFACX (11.64) and PAEAX (11.46) have marching annual gain over last year. PAEAX return over 5 years is better than : 27.41 vs. IFACX (17.65).
IFACXPAEAXIFACX / PAEAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years31 years-
Gain YTD2.5823.19381%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets128B2.73B4,692%
Annual Yield % from dividends2.882.10137%
Returns for 1 year11.6411.46102%
Returns for 3 years6.0416.5436%
Returns for 5 years17.6527.4164%
Returns for 10 years29.1542.1469%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFSL12.50-0.08
-0.64%
TFS Financial Corp
HBAN16.86-0.24
-1.40%
Huntington Bancshares
BY28.27-0.41
-1.43%
Byline Bancorp
SLN5.43-0.13
-2.34%
Silence Therapeutics Plc
CLDI0.76-0.07
-8.46%
Calidi Biotherapeutics